Issue navigation
Volume 188, Issue 4, April 2023
Commentary
Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?—that is the question
Jacqueline Trouillas and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages C1–C5, https://doi.org/10.1093/ejendo/lvad042
Unsolicited Review
Pancreas transplantation today: quo vadis?
Abdulrahman O Al-Naseem and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages R73–R87, https://doi.org/10.1093/ejendo/lvad032
Invited Review
Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?
Dan Alexandru Niculescu and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages R88–R97, https://doi.org/10.1093/ejendo/lvad044
The clinical and biochemical significance of 11-oxygenated androgens in human health and disease
Karl-Heinz Storbeck and Michael W O’Reilly
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages R98–R109, https://doi.org/10.1093/ejendo/lvad047
Original Research
Testicular volume in 268 children and adolescents followed-up for childhood obesity—a retrospective cross-sectional study
R Cannarella and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages 331–342, https://doi.org/10.1093/ejendo/lvad033
Mild autonomous cortisol secretion in adrenal incidentalomas and risk of fragility fractures: a large cross-sectional study
Guido Zavatta and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages 343–352, https://doi.org/10.1093/ejendo/lvad038
Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature
Afiya Andrews and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages 353–365, https://doi.org/10.1093/ejendo/lvad039
Glucocorticoid receptor polymorphism BclI with increased glucocorticoid sensitivity has a positive influence on quality of life in endogenous Cushing's syndrome in remission
Lara Feldkamp and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages 366–374, https://doi.org/10.1093/ejendo/lvad043
Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome
Frederick Vogel and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages 375–384, https://doi.org/10.1093/ejendo/lvad041
In-depth proteomic signature of parathyroid carcinoma
Sung Hye Kong and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages 385–394, https://doi.org/10.1093/ejendo/lvad046
Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome
Vincent Amodru and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages 395–406, https://doi.org/10.1093/ejendo/lvad008
Rare benign adrenal lesions
Prerna Dogra and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages 407–420, https://doi.org/10.1093/ejendo/lvad036
Brief Report
Immunohistochemical characterization of a steroid-secreting oncocytic adrenal carcinoma responsible for paraneoplastic hyperparathyroidism
Magalie Haissaguerre and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages K11–K16, https://doi.org/10.1093/ejendo/lvad025
Pubertal development and hypogonadism in males with autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy: a retrospective study
Emilia Träskilä and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages K17–K23, https://doi.org/10.1093/ejendo/lvad034
Ovarian stimulation does not induce thyrotropin receptor autoantibodies in women with thyroid autoimmunity
Kris Gustave Poppe and others
European Journal of Endocrinology, Volume 188, Issue 4, April 2023, Pages K24–K28, https://doi.org/10.1093/ejendo/lvad045
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals